English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduGenetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the journal Cancer Research by investigators at the GW Cancer Center.
Tag: GW Cancer Center
Supportive Oncodermatology Interventions Improve Patient Quality of Life
A recent survey from the GW Cancer Center found that enrollment in a supportive oncodermatology program is associated with a significantly improved quality of life score. The results are published in the Journal of Drugs in Dermatology.
GW Dermatology Experts Available to Speak During Skin Cancer Awareness Month
WASHINGTON (April 28, 2020) — Skin cancer is one of the most common types of cancers, with 1 in 5 Americans developing it by the age of 70 and representing 1% of all cancer-related deaths according to the National Cancer…
GW Cancer Center Expands Clinical Trial Offerings for Patients with High Risk Cutaneous Squamous Cell Carcinoma
The Cutaneous Oncology Program at the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma. The study, sponsored by Regeneron, will examine outcomes for patients treated with Libtayo® (cemiplimab) — an immunotherapy treatment — prior to surgery and radiation therapy.
GW Experts Are Available to Speak for Stories during Lung Cancer Awareness Month
WASHINGTON (Oct. 30, 2019) — November is Lung Cancer Awareness Month and according to the American Cancer Society, more than 220,000 new cases of lung cancer are diagnosed each year. The George Washington University (GW) Cancer Center has various experts…
GW Experts Available During Breast Cancer Awareness Month
WASHINGTON (Sept. 24, 2019) – Breast cancer is the second most commonly diagnosed cancer in women in the United States, with the American Cancer Society predicting more than 250,000 new cases in 2019. October is Breast Cancer Awareness Month and…
GW Cancer Center Researchers Find Potential Therapeutic Target for Prostate Cancers with PTEN Mutation
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function. These findings were published by George Washington University Cancer Center researchers in Nature Communications.
Researchers Identify Protein Governing Platinum Resistant Ovarian Cancer
Researchers at the GW Cancer Center have identified the protein ERK as an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer. The study is published in Clinical Cancer Research.